Injective (INJ) Surges 15% Amid EVM Testnet Launch and Strategic Partnerships

1. Executive Summary

Injective (INJ) has emerged as one of the week’s top-performing cryptocurrencies, rallying 15.26% after breaking out of a multi-month descending channel. Key drivers include the launch of its Ethereum Virtual Machine (EVM) testnet, a 1,500% spike in daily active addresses, and the formation of the Injective Council in collaboration with Google Cloud and Deutsche Telekom. These developments underscore Injective’s growing influence in decentralized finance (DeFi) and institutional adoption, signaling further bullish potential.

2. Recent Market Developments

EVM Testnet Launch Fuels Activity GrowthInjective’s EVM testnet launch on July 9 has set the stage for a transformational phase. The testnet enhances compatibility with Ethereum-based assets, making Injective a prime contender for real-world asset tokenization. This milestone coincided with a stunning 1,700% increase in daily active addresses since January, reaching over 82,000, the highest activity level since December 2023.

Strategic Partnerships with Google Cloud and Deutsche TelekomOn July 12, Injective announced the formation of the Injective Council, which includes industry leaders like Google Cloud and Deutsche Telekom. This council aims to accelerate institutional integration and innovation in DeFi, opening doors for global asset tokenization and broader adoption.

Technical Breakout and Bullish MomentumInjective’s price broke out of a long-standing descending channel, surging 15% to trade above $12. This movement was supported by rising trading volumes and positive funding rates, reflecting strong trader confidence. Analysts are now eyeing resistance levels at $14.16 and $15.43 for further upside.

On-Chain Usage Spikes by 1,500%Injective’s on-chain usage has surged dramatically, with daily active addresses increasing 1,500% since January 2025. This growth highlights the success of the Nivara Upgrade and testnet launch, which have driven user and developer engagement to new heights.

3. Technical Analysis

Current Price: $12.33
24h Volume: $18,200,822
Trend: Weak Bullish

Moving Averages:- Short-term indicators such as the 7-day SMA ($11.57) and 20-day SMA ($11.15) suggest bullish momentum.

Momentum Indicators:- RSI (14): 58.54 – Indicates moderate bullish momentum, with room for further gains.- MACD: Positive histogram of 0.2390 confirms bullish momentum, supported by a MACD line above the signal line.

Bollinger Bands:- The price is nearing the upper band ($12.49), signaling potential resistance but also indicating strong upward pressure.

Key Levels:- Resistance 1: $13.16- Resistance 2: $15.48- Support 1: $10.07- Support 2: $8.95

4. Trading Strategy and Signals

Given the recent breakout and bullish indicators, traders should monitor the following:- A confirmed close above $13.16 could signal further upside toward $15.48.- A retest of the broken descending trendline around $12.00 could present an ideal entry point for long positions.- Stop-loss orders should be placed near $10.07 to manage downside risk.

For short-term traders, momentum indicators like RSI and MACD suggest potential for quick gains, but caution is advised near key resistance zones.

5. Price Predictions and Outlook

If bullish momentum sustains:- Short-term Target: $14.16 (Resistance 1)- Mid-term Target: $15.48 (Resistance 2)

In the long term, Injective’s focus on real-world asset tokenization and institutional partnerships could drive its price back toward its 52-week high of $34.02. However, breaking the $15.48 resistance will be critical for sustained growth.

6. Risk Analysis

While Injective’s recent developments are promising, traders must consider the following risks:- Market Volatility: Broader crypto market sentiment remains uncertain, which could impact INJ’s momentum.- Resistance Levels: Failure to break key resistance zones at $14.16 and $15.48 could lead to a pullback.- Macro Factors: Regulatory pressures and economic uncertainty may influence institutional adoption and overall market conditions.

7. Conclusion

Injective (INJ) is gaining significant traction, underpinned by its EVM testnet launch, soaring on-chain activity, and strategic partnerships with global giants like Google Cloud. Technically, the breakout above $12 signals bullish momentum, with analysts eyeing $14.16 and $15.48 as key resistance levels. While risks remain, Injective’s focus on DeFi innovation and institutional integration positions it as a strong contender for long-term growth. Traders should remain vigilant for pullbacks and capitalize on buying opportunities near key support levels.

Image source: Shutterstock